{"schema_version":"secwatch.filing_event.v1","accession":"0000320335-26-000029","form_type":"8-K","ticker":"GL","cik":"0000320335","company_name":"GLOBE LIFE INC.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.362163+00:00","generated_at":"2026-05-16T05:07:49.598783+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Globe Life Q4 net operating income $3.39, up 8% YoY; FY25 net op inc $14.52; FY26 guidance $14.95-$15.65","bullets":["Q4 net income $3.29/share vs $3.01 YoY; net operating income $3.39 vs $3.14, up 8%.","FY25 net operating income $14.52/share vs $12.37, above previous guidance midpoint; net income $14.07 vs $11.94.","Life net sales up 11%; Health net sales up 71% led by United American ($77M vs $30M YoY).","Share repurchase: Q4 1.3M shares for $170M at avg $134.44; FY25 5.4M shares for $685M.","FY26 net operating income guidance $14.95-$15.65 per share, up from prior guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0000320335-26-000029","json":"https://secwatch.observer/filing/0000320335-26-000029.json","markdown":"https://secwatch.observer/filing/0000320335-26-000029.md","text":"https://secwatch.observer/filing/0000320335-26-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320335/000032033526000029/0000320335-26-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320335/000032033526000029/gl-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:07:49.598783+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}